Elexacaftor/tezacaftor/ivacaftor, sold under the brand names Trikafta and Kaftrio, is a fixed-dose combination medication used to treat cystic fibrosis. [8][9] Elexacaftor/tezacaftor/ivacaftor is …

Kaftrio is an effective treatment for patients with cystic fibrosis who have at least one F508del mutation in the CFTR gene. These patients have a high unmet medical need. In terms of …

Read about the triple combination therapy Kaftrio (known as Trikafta in the United States), which combines ivacaftor, tezacaftor and elexacaftor, and find out how it could help to treat people …

9 hours ago · By boosting the activity of the mutated protein, the modulator therapy has been proven to help ease CF symptoms in patients with responsive mutations.. Kaftrio is approved …

Nov 23, 2023 · Kaftrio is the latest of these CFTR modulator treatments and consists of a triple treatment combination of ivacaftor, tezacaftor, and elexacaftor. It’s a long term treatment for …

Therapeutic Indications: Kaftrio is indicated in a combination regimen with ivacaftor 150 mg tablets for the treatment of cystic fibrosis (CF) in patients aged 12 years and older who are …

What is Kaftrio and what is it used for? Kaftrio is a medicine used to treat patients aged 2 years and above who have cystic fibrosis, an inherited disease that has severe effects on the lungs, …

Kaftrio tablets are indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one F508del mutation in the …

5 days ago · Kaftrio granules are indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (CF) in paediatric patients aged 2 to less than 6 years who have at …

Kaftrio contains three active substances: ivacaftor, tezacaftor and elexacaftor. The medicine helps lung cells to work better in some patients with cystic fibrosis (CF). CF is an inherited condition …